TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.28 EUR | +1.61% |
|
+2.25% | -6.33% |
| 06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
| 06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Other Pharmaceuticals | +0.92% | +2.25% | -6.33% | -15.05% | -21.95% | 40.6B | - | - | - |
